Invoy

Market position

Invoy positions breath-based metabolic measurement as an alternative to the scale and to invasive testing or drug-based approaches, starting with obesity and aiming to extend breath diagnostics into proactive management of chronic metabolic conditions. A third-party directory places it in the wellness and fitness services industry and lists connected health and diabetes-device companies as comparables.

Non-invasive, drug-free, real-time daily measurement of fat metabolism through patented breath acetone sensing, rather than weight or lab testing, combined with human coaching delivered in-app and an explicit link to the member's clinician. The company also cites more than a decade of respiratory-chemistry research and its intellectual property position.

Technology

Patented breath chemistry sensing implemented in a portable handheld device paired with disposable breath pods. The sensor measures acetone, a volatile compound the company says is produced and exhaled when the body breaks down stored fat, and the reading is converted into a metabolic score in the Invoy app. The company states its breath biomarker platform also addresses signals such as inflammation and gut health. A third-party directory lists a technology stack including Amazon S3, React, Next.js, Zendesk, Assembly and C++ with HIPAA alignment.

Go-to-market

Direct-to-consumer sign-up via the Invoy app and website combined with distribution through select healthcare partnerships that offer discounted pricing; prospective members are asked to contact their provider or to call or text Invoy to enroll. A 14-day introductory experience is promoted on the website, and enterprise employer programs are cited as an additional route to market.

Individual consumers seeking weight management and metabolic tracking; patients referred through physicians and clinics, with the program positioned as an adjunct to provider care; and employers or enterprise partners running employee well-being programs. The company's site also maintains dedicated sections for doctors and investors.

Geography

Headquartered in Irvine, California, with an earlier site notice citing California as its base; a third-party profile reports employees across North America and Asia. Community and clinical work has been conducted in Raleigh, North Carolina and at Nicklaus Children's Hospital.

History

Invoy grew out of more than a decade of respiratory-chemistry research, beginning as a small team exploring a breath analyzer without a fixed application. Leadership at Nicklaus Children's Hospital brought the team into pediatric endocrinology, the ICU and neurology, where the team began framing breath analysis as a non-judgmental way to support children navigating obesity without scales or food tracking. Invoy then worked with low-income families in Raleigh, North Carolina, conducting breath testing in homes and support circles and identifying chemical signatures tied to fat metabolism. The company subsequently attracted enterprise partners and, per its own account, now offers a suite of solutions built on its intellectual property, real-world validation and an experienced team. A related entity, Invoy Technologies, LLC, was reported to have partnered with UP Technologies (China) Ltd. in April 2021 on development of an in-app food tab.